The regulatory and scientific landscape surrounding gluten-free food has moved faster in recent months than in the previous decade. New diagnostic guidelines, changes in European labeling, recent data on the gut microbiome: we take stock of the advancements that are concretely altering the management and availability of gluten-free products.
Diagnosis of celiac disease without biopsy: what the BSG 2026 guideline changes
The British Society of Gastroenterology published a major update to its recommendations on celiac disease in adults in July 2026. The central point: in certain symptomatic patients followed in specialized care, whose IgA anti-transglutaminase antibody levels exceed ten times the normal, the diagnosis can now be made without duodenal biopsy, after shared decision-making with the clinician.
Its extension to adults represents a turning point for gastroenterologists faced with patients reluctant to undergo endoscopy or in healthcare systems where access to biopsy is lengthy.
We regularly find information on gourmandsansgluten.fr that relays these medical advancements and their impact on the daily lives of those affected.
The BSG 2026 guideline maintains a non-negotiable condition: the patient must consume gluten before serological tests. Eliminating gluten before the biological assessment remains the primary cause of false negatives, a trap we still frequently observe in consultations.
A more structured post-diagnostic follow-up
The recommendations emphasize regular support during the first two years following diagnosis. This includes the involvement of a specialized dietitian, targeted nutritional assessment (iron, calcium, vitamin D, folates), and monitoring of adherence to the diet.
A technical point to remember: no single test can reliably verify adherence to the gluten-free diet. The combination of serology, dietary assessment, and symptomatology remains the only relevant approach.
Gut microbiome and celiac disease: recent data
Several publications released in 2026 confirm that celiac disease is accompanied by persistent changes in the intestinal microbiome, even in patients who have been on a strict diet for several years.
For practice, this means that the gluten-free diet alone is not always sufficient to restore the intestinal ecosystem. The intake of diverse fibers (vegetables, legumes, pseudo-cereals like buckwheat or quinoa) deserves particular attention in dietary recommendations.
Hidden gluten labeling: towards a risk assessment rather than vague mentions
The European regulatory approach to “may contain gluten” labels is changing its philosophy. Recent international guidelines favor a quantitative scientific assessment of the risk of cross-contamination, rather than the systematic application of precautionary labels.
Specifically, manufacturers are encouraged to:
- Conduct a documented risk analysis on each production line, identifying points of cross-contamination with ingredients containing wheat, barley, or rye
- Reserve the “may contain” label for situations where the residual risk is real and quantified, and not as a legal umbrella
- Provide consumers with more reliable information on the actual presence of gluten traces in processed products
For people with celiac disease, this evolution is significant. The proliferation of precautionary labels on foods had ultimately made labeling hard to read, unnecessarily excluding products whose contamination was actually negligible.
Allergens in restaurants: strengthened obligations and controls
In France, regulations require restaurants to inform their customers about the presence of the fourteen major allergens, including gluten. Controls have intensified in recent years, and penalties for non-compliance are no longer symbolic.
Restaurateurs offering gluten-free recipes must be able to justify the traceability of their ingredients and the measures taken to avoid cross-contamination in the kitchen. A dish labeled “gluten-free” prepared on the same work surface as wheat pasta does not meet regulatory requirements.
We recommend that food service professionals formalize their allergen management procedures in writing. A simple display is no longer sufficient: a traceability document for each dish provides the best protection in case of inspection or dispute.
What celiac customers should check
- Ask if the restaurant has a separate allergen menu or a consultable register
- Verify that gluten-free dishes are prepared with dedicated utensils or cleaned according to a documented protocol
- Prefer establishments that mention their gluten-free product suppliers, a sign of a structured approach
European gluten-free market: growth driven by reformulation
The European gluten-free product market continues to grow, but the dynamics have changed. Growth no longer primarily comes from new consumers adopting the diet by choice. It is now driven by the reformulation of existing products: improvements in textures, reduction of additives, and enrichment in fibers and plant proteins.
Manufacturers are investing in alternative flours (chickpea, lentil, teff, millet) that provide a more complete nutritional profile than traditional blends based on corn and rice starch. This trend addresses a recurring criticism: many first-generation gluten-free products had high glycemic indexes and low nutritional density.
The segment of artisanal gluten-free baking is also structuring, with bakers specifically trained in wheat-free baking techniques. Gluten-free bread is no longer a spongy substitute: long fermentation methods applied to buckwheat or brown rice flours produce results that celiac patients have long awaited.
Gluten-free eating is entering a phase of maturity where the organoleptic and nutritional quality catches up with that of conventional products. Diagnostic advancements, increased labeling rigor, and data on the microbiome are shaping a more reliable ecosystem for both patients and healthcare professionals.
